Abstract Proton Pump Inhibitors are used widely to manage many gastric acid-related
conditions such as gastroesophageal disease, gastritis, esophagitis, Barrett's esophagus …

Since their approval by the Food and Drug Administration (FDA) in 1989, proton pump
inhibitors (PPIs) have become one of the most highly utilized drugs in the United States …

Tacrolimus is a calcineurin inhibitor used to prevent rejection in allogenic solid organ
transplant recipients, which is metabolized in the liver with cytochrome P450 isoforms 3A4 …

Proton pump inhibitors (PPIs) are widely prescribed in medical practice for the treatment of
several gastrointestinal disorders. Previous epidemiology studies have reported the …

Proton pump inhibitors are widely used in the treatment of various acid-related diseases and
are among the most commonly used drugs. Studies estimate that 25–70% of proton pump …

Abstract Background: Proton pump inhibitors (PPIs) are commonly prescribed medications
for dyspepsia and gastroesophageal reflux. There are concerns about their use in the …

Abstract Background Proton pump inhibitors (PPIs) are widely used for the treatment of
gastrointestinal disorders such as peptic ulcer disease and dyspepsia. However, several …

Proton pump inhibitors (PPIs) are widely prescribed medications for the management of
various gastrointestinal disorders, primarily gastroesophageal reflux disease (GERD) and …

Aims Misoprostol is a prostaglandin E1 analogue that is used to prevent nonsteroidal anti‐
inflammatory drug (NSAID)‐induced gastrointestinal disorders. The aim of this systematic …

ABSTRACT Introduction Proton pump inhibitors (PPIs) are the first-line treatment for
gastroesophageal reflux disease (GERD). However, due to their intrinsic limitations, there …